Dehydroepiandrosterone (DHEA) Clinical Trials

• Effects of Dehydroepiandrosterone (DHEA) in Humans
  ClinicalTrials.gov Identifier: NCT00182975 - Active, not recruiting
  Aging
  
• A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)
  ClinicalTrials.gov Identifier: NCT00419913 - Recruiting
  Infertility; Decreased Ovarian Reserve
  
• Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly
  ClinicalTrials.gov Identifier: NCT00111930 - Completed
  Healthy
  
• ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction
  ClinicalTrials.gov Identifier: NCT00202163 - Recruiting
  Erectile Dysfunction
  
• Effect of Dehydroepiandrosterone (DHEA) on Hot Flashes in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00317148 - Active, not recruiting
  Hot Flashes
  
• Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00516542 - Recruiting
  Breast Cancer
  
• Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
  ClinicalTrials.gov Identifier: NCT00189124 - Recruiting
  Systemic Lupus Erythematosus
  
• Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans
  ClinicalTrials.gov Identifier: NCT00099697 - Completed
  Aging; Obesity; Insulin Resistance
  
• Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
  ClinicalTrials.gov Identifier: NCT00581087 - Not yet recruiting
  Chronic Obstructive Pulmonary Disease; Hypertension, Pulmonary
  
• Dehydroepiandrosterone Effects on HIV-1 Replication
  ClinicalTrials.gov Identifier: NCT00065104 - Completed
  HIV Infections
  
• An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients with Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00106314 - Completed
  Crohn's Disease
  
• DHEA and Testosterone Replacement in Elderly
  ClinicalTrials.gov Identifier: NCT00254371 - Completed
  Aging; Low DHEA for Women; Low Testosterone and DHEA for Men
  
• Study to Evaluate the Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms
  ClinicalTrials.gov Identifier: NCT00289926 - Active, not recruiting
  Decreased Libido; Quality of Life; Menopausal Symptoms
  
• DHEA Replacement in Adrenalectomized/Hypoadrenal Patients
  ClinicalTrials.gov Identifier: NCT00279929 - Completed
  Aging; Dehydroepiandosterone Replacement; DHEA Replacement
  
• Effect of DHEA on Skin Aging in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00248989 - Active, not recruiting
  Skin Aging; Quality of Life
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency
  ClinicalTrials.gov Identifier: NCT00004313 - Completed
  Addison's Disease
  
• DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy
  ClinicalTrials.gov Identifier: NCT00429806 - Active, not recruiting
  Vaginal Atrophy
  
• Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006219 - Active, not recruiting
  Multiple Myeloma
  
• Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido
  ClinicalTrials.gov Identifier: NCT00566384 - Recruiting
  Decreased Libido
  
• DHEA Treatment for Sjogren's Syndrome
  ClinicalTrials.gov Identifier: NCT00001598 - Completed
  Lacrimal Apparatus Disease; Salivary Gland Disease; Sjogren's Syndrome; Xerostomia
  
• DHEA Supplementation for Low Ovarian Response IVF Patients
  ClinicalTrials.gov Identifier: NCT00549081 - Not yet recruiting
  Infertility, Female; In-Vitro Fertilization
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women with Active Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00004662 - Completed
  Systemic Lupus Erythematosus
  
• Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women with Mild to Moderate Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00004795 - Completed
  Systemic Lupus Erythematosus
  
• Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00004665 - Completed
  Systemic Lupus Erythematosus
  
• Effects of DHEA and Exercise in the Elderly
  ClinicalTrials.gov Identifier: NCT00205686 - Completed
  Healthy Volunteers
  
• Does DHEA Enhance the Effects of Exercise in Postmenopausal Women?
  ClinicalTrials.gov Identifier: NCT00434915 - Completed
  Aging
  
• Six Months DHEA Treatment in Female Adrenal Failure
  ClinicalTrials.gov Identifier: NCT00471900 - Completed
  Adrenal Insufficiency
  
• Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency
  ClinicalTrials.gov Identifier: NCT00575341 - Completed
  Adrenal Insufficiency
  
• Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria
  ClinicalTrials.gov Identifier: NCT00442403 - Suspended
  Malaria
  
• Efficacy and Safety of DHEA for Myotonic Dystrophy
  ClinicalTrials.gov Identifier: NCT00167609 - Completed
  Myotonic Dystrophy
  
• Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
  ClinicalTrials.gov Identifier: NCT00391924 - Completed
  Lupus Erythematosus, Systemic; Sjogren's Syndrome
  
• Treatment of Mid-Life-Related Mood Disorders
  ClinicalTrials.gov Identifier: NCT00001487 - Completed
  Depressive Disorder; Mood Disorder
  
• Epidemiology of Insulin and Dehydroepiandrosterone Sulfate and Coronary Heart Disease Mortality
  ClinicalTrials.gov Identifier: NCT00005246 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease